{"name": "Alder Biopharmaceuticals",
 "permalink": "alder-biopharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/alder-biopharmaceuticals",
 "homepage_url": "http://www.alderbio.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2004,
 "founded_month": 1,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@alderbio.com",
 "phone_number": "425-205-2900",
 "description": "",
 "created_at": "Thu Jan 21 11:23:46 UTC 2010",
 "updated_at": "Wed Mar 27 14:40:19 UTC 2013",
 "overview": "\u003Cp\u003EAlder has worked to make a significant contribution to the field of antibody therapeutics using two proprietary platform technologies that accelerate antibody discovery and development. These technologies provide the foundation for addressing a range of unmet medical needs, and have allowed them to accelerate their first product into the clinic for the treatment of cancer and rheumatoid arthritis.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       58],
      "assets/images/resized/0007/4310/74310v1-max-150x150.jpg"],
     [[167,
       65],
      "assets/images/resized/0007/4310/74310v1-max-250x250.jpg"],
     [[167,
       65],
      "assets/images/resized/0007/4310/74310v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Randall",
      "last_name": "Schatzman",
      "permalink": "randall-schatzman",
      "image": null}},
   {"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Randall",
      "last_name": "C. Schatzman",
      "permalink": "randall-c-schatzman",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, Finance",
    "person":
     {"first_name": "Larry",
      "last_name": "Benedict",
      "permalink": "larry-benedict",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$53M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/alder-lands-15m-milestone-blockbuster-bms-antibody-deal/2011-06-20?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Alder lands $15M milestone from blockbuster BMS antibody deal",
    "raised_amount": 15000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 6,
    "funded_day": 20,
    "investments":
     []},
   {"round_code": "d",
    "source_url": "http://www.prnewswire.com/news-releases/alder-biopharmaceuticals-inc-closes-38-million-series-d-financing-to-accelerate-clinical-development-of-its-pipeline-of-antibody-therapeutics-148069675.html",
    "source_description": "Alder BioPharmaceuticals Inc. Closes $38 Million Series D Financing to Accelerate Clinical Development of its Pipeline of Antibody Therapeutics",
    "raised_amount": 38000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 4,
    "funded_day": 19,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Novo Ventures",
         "permalink": "novo-ventures",
         "image":
          {"available_sizes":
            [[[133,
               56],
              "assets/images/resized/0004/6080/46080v2-max-150x150.jpg"],
             [[133,
               56],
              "assets/images/resized/0004/6080/46080v2-max-250x250.jpg"],
             [[133,
               56],
              "assets/images/resized/0004/6080/46080v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sevin Rosen Funds",
         "permalink": "sevin-rosen-funds",
         "image":
          {"available_sizes":
            [[[98,
               87],
              "assets/images/resized/0003/0241/30241v1-max-150x150.jpg"],
             [[98,
               87],
              "assets/images/resized/0003/0241/30241v1-max-250x250.jpg"],
             [[98,
               87],
              "assets/images/resized/0003/0241/30241v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Ventures West",
         "permalink": "ventures-west",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0001/0785/10785v1-max-150x150.png"],
             [[240,
               74],
              "assets/images/resized/0001/0785/10785v1-max-250x250.png"],
             [[240,
               74],
              "assets/images/resized/0001/0785/10785v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "WRF Capital",
         "permalink": "wrf-capital",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0000/2731/2731v1-max-150x150.png"],
             [[200,
               58],
              "assets/images/resized/0000/2731/2731v1-max-250x250.png"],
             [[200,
               58],
              "assets/images/resized/0000/2731/2731v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "H.I.G. Ventures",
         "permalink": "h-i-g-ventures",
         "image":
          {"available_sizes":
            [[[150,
               67],
              "assets/images/resized/0010/2205/102205v1-max-150x150.jpg"],
             [[206,
               93],
              "assets/images/resized/0010/2205/102205v1-max-250x250.jpg"],
             [[206,
               93],
              "assets/images/resized/0010/2205/102205v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Delphi Ventures",
         "permalink": "delphi-ventures",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0004/5369/45369v1-max-150x150.png"],
             [[206,
               82],
              "assets/images/resized/0004/5369/45369v1-max-250x250.png"],
             [[206,
               82],
              "assets/images/resized/0004/5369/45369v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "TPG Biotech",
         "permalink": "tpg-biotech",
         "image":
          {"available_sizes":
            [[[150,
               89],
              "assets/images/resized/0011/4964/114964v1-max-150x150.png"],
             [[234,
               139],
              "assets/images/resized/0011/4964/114964v1-max-250x250.png"],
             [[234,
               139],
              "assets/images/resized/0011/4964/114964v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "11804 North Creek Parkway",
    "address2": "",
    "zip_code": "98011",
    "city": "South Bothell",
    "state_code": "WA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}